Sumitomo Mitsui Trust Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82M Sell
1,152,200
-55,430
-5% -$4.37M 0.05% 325
2025
Q4
$99M Sell
1,207,630
-15,074
-1% -$1.17M 0.06% 292
2025
Q3
$91.8M Buy
1,222,704
+20,307
+2% +$1.51M 0.05% 316
2025
Q2
$89.1M Buy
1,202,397
+93,989
+8% +$6.54M 0.06% 321
2025
Q1
$89.5M Buy
1,108,408
+22,084
+2% +$1.9M 0.06% 299
2024
Q4
$84.9M Buy
1,086,324
+63,928
+6% +$5.43M 0.06% 318
2024
Q3
$96M Buy
1,022,396
+23,448
+2% +$1.97M 0.07% 294
2024
Q2
$77.8M Sell
998,948
-26,372
-3% -$2.15M 0.06% 323
2024
Q1
$93.2M Buy
1,025,320
+20,776
+2% +$1.73M 0.06% 318
2023
Q4
$77.7M Sell
1,004,544
-10,645
-1% -$745K 0.06% 351
2023
Q3
$69.1M Sell
1,015,189
-6,339
-0.6% -$461K 0.06% 361
2023
Q2
$83M Buy
1,021,528
+911
+0.1% +$72.7K 0.06% 323
2023
Q1
$83.7M Buy
+1,020,617
New +$72.9M 0.06% 342

Other funds holding GEHC

Sumitomo Mitsui Trust Group's GEHC Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its GE HealthCare (GEHC) stake by 4.6% in Q1 2026, selling an estimated $4.37M and leaving 1,152,200 shares worth $82M. The position accounts for 0.05% of the portfolio, ranked #325.

Sumitomo Mitsui Trust Group first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $99M in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 1,152,200 shares of GE HealthCare worth $82M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 55,430 GE HealthCare shares in Q1 2026, an estimated $4.37M.
  • GE HealthCare made up 0.05% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #325 holding.
  • Sumitomo Mitsui Trust Group first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Sumitomo Mitsui Trust Group's GE HealthCare position peaked at $99M in Q4 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.